Circassia Pharmaceuticals Plc TR1 Notification of Major Interest in Shares (0938Q)
June 12 2015 - 12:33PM
UK Regulatory
TIDMCIR TIDMAV.
RNS Number : 0938Q
Circassia Pharmaceuticals Plc
12 June 2015
For filings with the FCA include the
annex
For filings with issuer exclude the
annex
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i)
---------------------------------------------------------------------------------------------------
1. Identity of the issuer or the underlying Circassia Pharmaceuticals Plc
issuer
of existing shares to which voting rights
are
attached: (ii)
------------------------------------------------------ -------------------------------------------
2 Reason for the notification (please tick the appropriate box or boxes):
---------------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights
----------------------------------------------------------------------------------------- --------
An acquisition or disposal of qualifying financial instruments
which may result in the acquisition of shares already issued to
which voting rights are attached
----------------------------------------------------------------------------------------- --------
An acquisition or disposal of instruments with similar economic
effect to qualifying financial instruments
----------------------------------------------------------------------------------------- --------
An event changing the breakdown of voting rights
----------------------------------------------------------------------------------------- --------
Other (please specify): CHANGE TO THE NUMBER OF VOTING RIGHTS IN ISSUE,
FOLLOWING THE RECENT PLACING AND OPEN OFFER
------------------------- -------------------------------------------------------------- --------
3. Full name of person(s) subject Aviva plc & its subsidiaries
to the
notification obligation: (iii)
-------------------------------------------- -----------------------------------------------------
4. Full name of shareholder(s) Registered Holder:
(if different from 3.):(iv)
BNY Norwich Union Nominees Limited
1,799,587*
Chase (GA Group) Nominees Limited 16,663,358*
Chase Nominees Limited 108,046*
Available on Request 5,000*
* denotes direct interest
BNY (Nominees) Limited 127,294
Chase (GA Group) Nominees Limited 535,385
Chase Nominees Limited 815,323
Vidacos Nominees Limited 1,899,303
-------------------------------------------- -----------------------------------------------------
5. Date of the transaction and date 11 June 2015
on
which the threshold is crossed
or
reached: (v)
-------------------------------------------- -----------------------------------------------------
6. Date on which issuer notified: 12 June 2015
-------------------------------------------- -----------------------------------------------------
7. Threshold(s) that is/are crossed 5% to 6% Change at Direct Interest
or Level
reached: (vi, vii)
-------------------------------------------- -----------------------------------------------------
8. Notified details:
----------------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares (viii, ix)
----------------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the triggering
of to the triggering transaction
shares transaction
if possible
using
the ISIN CODE
-------------- -------------------------------- --------------------------------------------------------------------
Number Number Number Number of voting % of voting rights
of of of shares rights (x)
Shares Voting
Rights
-------------- ---------------- -------------- ----------- ---------------------------- -------------------------
Direct Direct Indirect Direct Indirect
(xi) (xii)
-------------- ------ -------- ------- ----- ----------- --------------- ----------- --------- --------------
Ordinary
Shares
GB00BJVD3B28 11,811,291 11,811,291 21,953,296 18,575,991 3,377,305 6.52% 1.19%
---------------- -------------- ----------- --------------- ----------- --------- --------------
B: Qualifying Financial Instruments
----------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------------------------------------------
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date (xiii) Conversion Period rights that may rights
(xiv) be
acquired if the
instrument is
exercised/ converted.
---------------------- ----------------- ------------------------ --------------------------- --------------------
C: Financial Instruments with similar economic effect to Qualifying Financial
Instruments (xv, xvi)
------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
------------------------------------------------------------------------------------------------------
Type of financial Exercise Expiration Exercise/ Number of voting % of voting rights
instrument price date (xvii) Conversion rights instrument (xix, xx)
period refers to
(xviii)
------------------ --------- ------------- ------------ ------------------- ---------------------
Nominal Delta
------------------ --------- ------------- ------------ ------------------- ----------- --------
Total (A+B+C)
------------------------------------------------------
Number of voting rights Percentage of voting rights
------------------------ ----------------------------
21,953,296 7.71%
------------------------ ----------------------------
9. Chain of controlled undertakings through which the voting rights and/or
the
financial instruments are effectively held, if applicable: (xxi)
---------------------------------------------------------------------------------
The voting rights are managed and controlled by Aviva Investors Global
Services Limited and Friends Provident International Limited, with the
following chains of controlled undertakings:-
Aviva Investors Global Services Limited:
* Aviva plc (Parent Company)
* Aviva Group Holdings Limited (wholly owned subsidiary
of Aviva plc)
* Aviva Investors Holdings Limited (wholly owned
subsidiary of Aviva Group Holdings Limited)
* Aviva Investors Global Services Limited (wholly owned
subsidiary of Aviva Investors Holdings Limited)
Friends Provident International Limited:
* Aviva plc (Parent Company)
* Aviva Group Holdings Limited (wholly owned subsidiary
of Aviva plc)
* Aviva Life Holdings UK Limited (wholly owned
subsidiary of Aviva Group Holdings Limited)
* Friends Life FPG Limited (wholly owned subsidiary of
Aviva Life Holdings UK Limited)
* Friends Life FPL Limited (wholly owned subsidiary of
Friends Life FPG Limited)
* Friends Life Limited (wholly owned subsidiary of
Friends Life FPL Limited)
* Friends Life and Pensions Limited (wholly owned
subsidiary of Friends Life Limited)
Friends Provident International Limited (wholly owned subsidiary of Friends
Life and Pensions Limited)
---------------------------------------------------------------------------------
Proxy Voting:
---------------------------------------------------------------------------------
10. Name of the proxy holder: See Section 4
--------------------------------------------------- ----------------------------
11. Number of voting rights proxy holder will
cease
to hold:
--------------------------------------------------- ----------------------------
12. Date on which proxy holder will cease to
hold
voting rights:
--------------------------------------------------- ----------------------------
13. Additional information: Figures are based on a total number
of voting rights of 284,889,171 as
per the Company's Total Voting Rights
Update Announcement of 11 June 2015.
-------------------------------------- -----------------------------------------
14. Contact name: Julien Cotta
-------------------------------------- -----------------------------------------
15. Contact telephone number: 01865 405560
-------------------------------------- -----------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLLLFFRRVIFLIE
Aviva (LSE:AV.)
Historical Stock Chart
From Apr 2024 to May 2024
Aviva (LSE:AV.)
Historical Stock Chart
From May 2023 to May 2024
